Literature DB >> 12594737

Lentiviral vectors for gene delivery to normal and demyelinated white matter.

Chao Zhao1, Padraig M Strappe, Andrew M L Lever, Robin J M Franklin.   

Abstract

Lentiviral vectors are increasingly used for gene delivery to neurons and in experimental models of neurodegeneration. Their use in gene delivery to white matter and their potential value in preventing or repairing CNS demyelination has received less attention. Here we show using a VSV-G-pseudotyped HIV-derived vector expressing the marker gene LacZ that lentiviral vectors transduce the major macroglial cell types present in normal white matter (astrocytes, oligodendrocytes, and oligodendrocyte progenitors). Injection of lentiviral vectors causes an inflammatory response at the injection site characterized by OX42(+) and ED1(+) macrophages, but only a few CD8(+) and no CD4(+) lymphocytes, and mild demyelination. Injection of lentiviral vectors into areas of toxin-induced demyelination resulted in significant numbers of cells expressing the marker gene and was a more effective means of gene delivery than was a LacZ-expressing murine retroviral vector. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12594737     DOI: 10.1002/glia.10195

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

2.  Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.

Authors:  Aline M Thomas; Jaime L Palma; Lonnie D Shea
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

3.  Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.

Authors:  Ahmed A Abdellatif; Jennifer L Pelt; Richard L Benton; Russell M Howard; Pantelis Tsoulfas; Peipei Ping; Xiao-Ming Xu; Scott R Whittemore
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

Review 4.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

5.  Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.

Authors:  Jigisha R Patel; Jessica L Williams; Megan M Muccigrosso; Laindy Liu; Tao Sun; Joshua B Rubin; Robyn S Klein
Journal:  Acta Neuropathol       Date:  2012-08-30       Impact factor: 17.088

6.  Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons.

Authors:  Rong-Rong Zhao; Elizabeth M Muir; João Nuno Alves; Hannah Rickman; Anna Y Allan; Jessica C Kwok; Kasper C D Roet; Joost Verhaagen; Bernard L Schneider; Jean-Charles Bensadoun; Sherif G Ahmed; Rafael J Yáñez-Muñoz; Roger J Keynes; James W Fawcett; John H Rogers
Journal:  J Neurosci Methods       Date:  2011-08-09       Impact factor: 2.390

7.  Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage.

Authors:  Padraig M Strappe; David W Hampton; Douglas Brown; Begona Cachon-Gonzalez; Maeve Caldwell; James W Fawcett; Andrew M L Lever
Journal:  Retrovirology       Date:  2005-09-16       Impact factor: 4.602

8.  Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.

Authors:  Thais Federici; Robert Kutner; Xian-Yang Zhang; Hitoshi Kuroda; Noël Tordo; Nicholas M Boulis; Jakob Reiser
Journal:  Genet Vaccines Ther       Date:  2009-01-13

9.  Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®.

Authors:  Simoneide Souza Titze de Almeida; Camila Hillesheim Horst; Cristina Soto-Sánchez; Eduardo Fernandez; Ricardo Titze de Almeida
Journal:  Molecules       Date:  2018-07-23       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.